As many biotech investors noticed, shares of Affymax exploded yesterday, up 54%, with an unheard of amount of trading volume. In this video, Motley Fool health-care analyst David Williamson unwinds some of the rumors that may have led to this stock's jump, and warns investors that taking a position in this stock right now isn't investing, it's gambling, and you may be betting on a very shaky horse.
While you can certainly make huge gains in biotech and pharmaceuticals, the best investing approach is to choose great companies and stick with them for the long-term. The Motley Fool's free report, "3 Stocks That Will Help You Retire Rich," names stocks that could help you build long-term wealth and retire well, along with some winning wealth-building strategies that every investor should be aware of. Click here now to keep reading.
The article Steer Clear of Affymax's Mysterious Pop originally appeared on Fool.com.
David Williamson has no position in any stocks mentioned. Follow him on Twitter: @MotleyDavid.
The Motley Fool has no position in any of the stocks mentioned. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.
Copyright © 1995 - 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.